2025-01-03 JinkoSolar Holding Co., Ltd. HaiPress
SHANGRAO,China,Dec. 27,2024 -- JinkoSolar Holding Co.,Ltd. ("JinkoSolar" or the "Company") (NYSE: JKS),one of the largest and most innovative solar module manufacturers in the world,today announced that all shareholders resolutions proposed at the Company's 2024 annual general meeting held today were duly passed. Specifically,the Company's shareholders passed the following resolutions approving:
The re-election of Mr. Xianhua Li as a director of the Company;
The re-election of Mr. Steven Markscheid as a director of the Company;
The ratification of the appointment of Mr. Gang Chu as an independent director of the Company and the re-election of him as an independent director of the Company;
The ratification of the appointment of PricewaterhouseCoopers Zhong Tian LLP as auditors of the Company for the fiscal year of 2024;
The authorization of the directors of the Company to determine the remuneration of the auditors of the Company; and
The authorization of each of the directors of the Company be authorized to take any and all action that might be necessary to effect the foregoing resolutions 1 to 5 as such director,in his or her absolute discretion,thinks fit.
About JinkoSolar Holding Co.,Ltd.
JinkoSolar (NYSE: JKS) is one of the largest and most innovative solar module manufacturers in the world. JinkoSolar distributes its solar products and sells its solutions and services to a diversified international utility,commercial and residential customer base in China,the United States,Japan,Germany,the United Kingdom,Chile,South Africa,India,Mexico,Brazil,the United Arab Emirates,Italy,Spain,France,Belgium,Netherlands,Poland,Austria,Switzerland,Greece and other countries and regions.
JinkoSolar had over 10 productions facilities globally,over 20 overseas subsidiaries in Japan,South Korea,Vietnam,Turkey,Australia,Canada,Malaysia,Denmark,Indonesia,Nigeria and Saudi Arabia,and a global sales network with sales teams in China,Vietnam and India,as of September 30,2024. To find out more,please see:www.jinkosolar.com
For investor and media inquiries,please contact:
In China:
Ms. Stella Wang
JinkoSolar Holding Co.,Ltd.
Tel: +86 21-5180-8777 ext.7806
Email: ir@jinkosolar.com
Mr. Rene Vanguestaine
Christensen
Tel: +86 178 1749 0483
Email: rene.vanguestaine@christensencomms.com
In the U.S.:
Ms. Linda Bergkamp
Christensen,Scottsdale,Arizona
Tel: +1-480-614-3004
Email: linda.bergkamp@christensencomms.com
Cangxi County Holds 2026 New Year's Cultural Performance for the Public
The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange
Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement
©copyright 2009-2020 Singapore Info Map